Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy E Lane

Showing results (41-50 of 361) with videos related to

Pageof 37
Sort By:
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|September 1, 2005
Changes in serum fibroblast growth factor 2 in patients with glucocorticoid-induced osteoporosis treated with human parathyroid hormone (1-34)Marja Hurley, Wei Yao, Nancy E Lane
Bone|March 10, 2012
Role of bone architecture and anatomy in osteoarthritisJulie C Baker-LePain, Nancy E Lane
The Journal of Rheumatology|December 5, 2002
Radiographic methods in knee osteoarthritis: a further comparison of semiflexed (MTP), schuss-tunnel, and weight-bearing anteroposterior views for joint space narrowing and osteophytesFrederick Wolfe, Nancy E Lane, Chris Buckland-Wright
Nature Reviews. Rheumatology|March 6, 2013
To Wnt or not to Wnt: the bone and joint health dilemmaRik J Lories, Maripat Corr, Nancy E Lane
Osteoarthritis and Cartilage Open|December 31, 2024
Slow acting medications for progressive and painful knee osteoarthritis. How do we assess the benefit to risk of these potentially novel therapies?Nancy E Lane, Lee S Simon, Jeyanesh Tambiah
The Journal of Clinical Endocrinology and Metabolism|July 9, 2004
Changes in serum receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, and interleukin-6 levels in patients with glucocorticoid-induced osteoporosis treated with human parathyroid hormone (1-34)Eric C Buxton, Wei Yao, Nancy E Lane
Nature Reviews. Rheumatology|November 21, 2020
The evolution of nerve growth factor inhibition in clinical medicineBarton L Wise, Matthias F Seidel, Nancy E Lane
Nutrition Journal|January 30, 2016
Efficacy and tolerability of an undenatured type II collagen supplement in modulating knee osteoarthritis symptoms: a multicenter randomized, double-blind, placebo-controlled studyJames P Lugo, Zainulabedin M Saiyed, Nancy E Lane
Best Practice & Research. Clinical Rheumatology|January 15, 2023
Osteoarthritis today: Lost in translation?Sarah Kennedy, Jeyanesh R S Tambiah, Nancy E Lane
Calcified Tissue International|February 23, 2018
Osteoporosis in Rheumatic Diseases: Anti-rheumatic Drugs and the SkeletonAlanna M Dubrovsky, Mie Jin Lim, Nancy E Lane
Pageof 37

Showing results (41-50 of 361) with videos related to

Sort By:
Pageof 37
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|September 1, 2005
Changes in serum fibroblast growth factor 2 in patients with glucocorticoid-induced osteoporosis treated with human parathyroid hormone (1-34)Marja Hurley, Wei Yao, Nancy E Lane
Bone|March 10, 2012
Role of bone architecture and anatomy in osteoarthritisJulie C Baker-LePain, Nancy E Lane
The Journal of Rheumatology|December 5, 2002
Radiographic methods in knee osteoarthritis: a further comparison of semiflexed (MTP), schuss-tunnel, and weight-bearing anteroposterior views for joint space narrowing and osteophytesFrederick Wolfe, Nancy E Lane, Chris Buckland-Wright
Nature Reviews. Rheumatology|March 6, 2013
To Wnt or not to Wnt: the bone and joint health dilemmaRik J Lories, Maripat Corr, Nancy E Lane
Osteoarthritis and Cartilage Open|December 31, 2024
Slow acting medications for progressive and painful knee osteoarthritis. How do we assess the benefit to risk of these potentially novel therapies?Nancy E Lane, Lee S Simon, Jeyanesh Tambiah
The Journal of Clinical Endocrinology and Metabolism|July 9, 2004
Changes in serum receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, and interleukin-6 levels in patients with glucocorticoid-induced osteoporosis treated with human parathyroid hormone (1-34)Eric C Buxton, Wei Yao, Nancy E Lane
Nature Reviews. Rheumatology|November 21, 2020
The evolution of nerve growth factor inhibition in clinical medicineBarton L Wise, Matthias F Seidel, Nancy E Lane
Nutrition Journal|January 30, 2016
Efficacy and tolerability of an undenatured type II collagen supplement in modulating knee osteoarthritis symptoms: a multicenter randomized, double-blind, placebo-controlled studyJames P Lugo, Zainulabedin M Saiyed, Nancy E Lane
Best Practice & Research. Clinical Rheumatology|January 15, 2023
Osteoarthritis today: Lost in translation?Sarah Kennedy, Jeyanesh R S Tambiah, Nancy E Lane
Calcified Tissue International|February 23, 2018
Osteoporosis in Rheumatic Diseases: Anti-rheumatic Drugs and the SkeletonAlanna M Dubrovsky, Mie Jin Lim, Nancy E Lane
Pageof 37